| |
| |
|
| Insider
Information: |
Roivant Sciences Ltd. |
| Relationship: |
|
| City: |
Hamilton |
| State: |
D0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
205,098,790 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,700,512,306 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
205,098,790 |
|
|
| Total
Value |
$1,700,512,306 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -49.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tekmira Pharmaceuticals Corp |
TKMR |
10% Owner |
2021-10-18 |
38,847,462 |
|
0 |
Premium* |
|
|
Sio Gene Therapies Inc |
SIOX |
10% Owner |
2020-02-24 |
18,577,380 |
|
0 |
Premium* |
|
|
Myovant Sciences Ltd. |
MYOV |
10% Owner |
2019-12-17 |
45,008,604 |
2019-12-27 |
0 |
Premium* |
|
|
Urovant Sciences Ltd. |
UROV |
10% Owner |
2019-06-19 |
22,860,013 |
2019-12-27 |
0 |
Premium* |
|
|
Immunovant Inc |
IMVT |
|
2023-10-02 |
79,805,331 |
2019-12-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMVT |
Immunovant Inc |
|
• • • |
2023-10-02 |
4 |
B |
$38.00 |
$58,000,008 |
D/D |
1,526,316 |
79,805,331 |
0.01 |
- |
|
| IMVT |
Immunovant Inc |
|
• • • |
2023-10-02 |
4 |
A |
$38.00 |
$169,999,992 |
D/D |
4,473,684 |
78,279,015 |
0 |
- |
|
| IMVT |
Immunovant Inc |
|
• • • |
2022-10-06 |
4 |
B |
$6.00 |
$2,500,002 |
D/D |
416,667 |
73,805,331 |
0.01 |
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
10% Owner |
– – • |
2021-10-18 |
4 |
A |
$0.00 |
$0 |
D/D |
22,833,922 |
38,847,462 |
0 |
- |
|
| IMVT |
Immunovant Inc |
10% Owner |
– – • |
2021-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,021,276 |
73,388,664 |
0 |
- |
|
| IMVT |
Immunovant Inc |
10% Owner |
– – • |
2020-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,773,969 |
56,367,388 |
0 |
- |
|
| IMVT |
Immunovant Inc |
10% Owner |
– – • |
2020-09-04 |
4 |
B |
$33.00 |
$12,540,000 |
D/D |
380,000 |
47,593,419 |
2.45 |
- |
|
| IMVT |
Immunovant Inc |
10% Owner |
– – • |
2020-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,773,969 |
47,213,419 |
0 |
- |
|
| IMVT |
Immunovant Inc |
10% Owner |
– – • |
2020-04-16 |
4 |
B |
$14.50 |
$15,000,004 |
D/D |
1,034,483 |
38,439,450 |
2.45 |
- |
|
| SIOX |
Sio Gene Therapies Inc |
10% Owner |
– – • |
2020-02-24 |
4 |
B |
$3.75 |
$19,999,999 |
D/D |
5,333,333 |
18,577,380 |
2.45 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
10% Owner |
– – • |
2019-12-27 |
4 |
S |
$0.00 |
$0 |
I/I |
(45,008,604) |
0 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-12-27 |
4 |
S |
$0.00 |
$0 |
I/I |
(22,860,013) |
0 |
0 |
- |
|
| IMVT |
Immunovant Inc |
10% Owner |
– – • |
2019-12-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
485,000 |
|
- |
|
| IMVT |
Immunovant Inc |
10% Owner |
– – • |
2019-12-18 |
4 |
A |
$10.00 |
$369,199,670 |
D/D |
36,919,967 |
37,404,967 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
10% Owner |
– – • |
2019-12-17 |
4 |
AB |
$15.94 |
$1,195,500 |
D/D |
75,000 |
45,008,604 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
10% Owner |
– – • |
2019-12-16 |
4 |
AB |
$14.97 |
$2,572,206 |
D/D |
170,000 |
44,933,604 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
10% Owner |
– – • |
2019-12-04 |
4 |
AB |
$17.04 |
$1,279,315 |
D/D |
75,000 |
44,763,604 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
10% Owner |
– – • |
2019-12-02 |
4 |
AB |
$18.21 |
$3,305,041 |
D/D |
179,193 |
44,688,604 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
10% Owner |
– – • |
2019-11-21 |
4 |
AB |
$11.80 |
$1,449,101 |
D/D |
121,906 |
41,009,411 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
10% Owner |
– – • |
2019-11-20 |
4 |
AB |
$12.90 |
$1,572,587 |
D/D |
121,906 |
40,887,505 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-19 |
4 |
AB |
$8.17 |
$40,495 |
D/D |
4,957 |
22,860,013 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-18 |
4 |
AB |
$8.21 |
$55,061 |
D/D |
6,706 |
22,855,056 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-17 |
4 |
AB |
$8.53 |
$55,825 |
D/D |
6,541 |
22,848,350 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-14 |
4 |
AB |
$7.91 |
$56,514 |
D/D |
7,144 |
22,841,809 |
0 |
- |
|
| UROV |
Urovant Sciences Ltd. |
10% Owner |
– – • |
2019-06-13 |
4 |
AB |
$7.95 |
$58,543 |
D/D |
7,367 |
22,834,665 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
